Induction of passive Heymann nephritis in complement component 6-deficient PVG rats

Journal of Immunology

Volumn 179, Issue 1, 2007, Pages 172-178

  Spicer, S Timothy ^a,d   Tran, Giang T ^a   Killingsworth, Murray C ^b   Carter, Nicole ^a   Power, David A ^c   Paizis, Kathy ^c   Boyd, Rochelle ^a   Hodgkinson, Suzanne J ^a   Hall, Bruce M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d Liverpool Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C6; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPLEMENT DEFICIENCY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS EPITHELIUM; HEYMANN NEPHRITIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN DEPOSITION; KIDNEY TUBULE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; T LYMPHOCYTE;

EID: 34250846979     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.179.1.172     Document Type: Article

References (61)

1. Heymann, W., D. Hackel, S. Harwood, S. Wilson, and J. Hunter. 1959. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc. Soc. Exp. Biol. Med. 100: 660-664.
2. Salant, D. J., S. Belok, M. P. Madaio, and W. G. Couser. 1980. A new role for complement in experimental membranous nephropathy in rats. J. Clin. Invest. 66: 1339-1350.
3. Alousi, M. A., R. S. Post, and W. Heymann. 1969. Experimental autoimmune nephrosis in rats: morphogenesis of the glomerular lesion: immunohistochemical and electron microscopic studies. Am. J. Pathol. 54: 47-71.
4. Kerjaschki, D., R. Ullrich, K. Diem, S. Pietromonaco, R. A. Orlando, and M. G. Farquhar. 1992. Identification of a pathogenic epitope involved in initiation of Heymann nephritis. Proc. Natl. Acad. Sci. USA 89: 11179-11183.
5. Saito, A., S. Pietromonaco, A. K. Loo, and M. G. Farquhar. 1994. Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc. Natl. Acad. Sci. USA 91: 9725-9729.
6. Couser, W. G. 1993. Mediation of immune glomerular injury. Clin. Invest. 71: 808-811.
7. Perkinson, D. T., P. J. Baker, W. G. Couser, R. J. Johnson, and S. Adler. 1985. Membrane attack complex deposition in experimental glomerular injury. Am. J. Pathol. 120: 121-128.
8. Couser, W. G. 1998. Pathogenesis of glomerular damage in glomerulonephritis. Nephrol. Dial. Transplant. 13: 10-15.
9. Leenaerts, P. L., B. M. Hall, D. B. J. Van, M. R. Daha, and Y. F. Vanrenterghem. 1995. Active Heymann nephritis in complement component C6 deficient rats. Kidney Int. 47: 1604-1614.
10. + T cell depletion prevents proteinuria in active Heymann nephritis. J. Exp. Med. 188: 1775-1784.
11. Leenaerts, P. L., R. K. Stad, B. M. Hall, D. B. J. Van, V. Vanrenterghem, and M. R. Daha. 1994. Hereditary C6 deficiency in a strain of PVG/c rats. Clin. Exp. Immunol. 97: 478-482.
12. Merten, S., J. C. Chen, H. Ha, K. Plain, R. A. Boyd, M. J. Penny, P. Leenaerts, and B. M. Hall. 1998. The cellular basis of cardiac allograft rejection. VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient rats. Transplantation 65: 1152-1158.
13. Spicer, S. T., H. Ha, R. A. Boyd, X. Y. He, N. Carter, G. Tran, M. J. Penny, S. J. Hodgkinson, and B. M. Hall. 2001. IL-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells. J. Immunol. 167: 3725-3733.
14. Kent, J. F., and E. H. Fife. 1963. Precise standardisation of reagents for complement fixation. Am. J. Trop. Med. 12: 103-116.
15. Ruddy, S. 1994. Complement. In Manual of Clinical Laboratory Immunology. N. R. Rose, E. C. de Macario, J. Fahey, H. Friedman, and G. M. Penn, eds. Lange, Washington, pp. 121-122.
16. Tran, G. T., S. J. Hodgkinson, N. Carter, M. Killingsworth, S. T. Spicer, and B. M. Hall. 2002. Attenuation of experimental allergic encephalomyelitis in complement component 6-deficient rats is associated with reduced complement C9 deposition, P-selectin expression, and cellular infiltrate in spinal cords. J. Immunol. 168: 4293-4300.
17. Salant, D. J., and A. V. Cybulsky. 1988. Experimental glomerulonephritis. Methods Enzymol. 162: 421-461.
18. de Heer, E., M. R. Daha, and L. A. van Es. 1984. Lymph node cells from rats with Heymann's nephritis produce in vitro autoantibodies directed against purified renal tubular antigen. Immunology 52: 743-752.
19. Edgington, T. S., R. J. Glassock, and F. J. Dixon. 1968. Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J. Exp. Med. 127: 555-571.
20. Paizis, K., G. Kirkland, M. Polihronis, M. Katerelos, J. Kanellis, and D. A. Power. 1998. Heparin-binding epidermal growth factor-like growth factor in experimental models of membranous and minimal change nephropathy. Kidney Int. 53: 1162-1171.
21. Misra, R. P. 1972. Isolation of glomeruli from mammalian kidneys by graded sieving. Am. J. Clin. Pathol. 58: 135-139.
22. Penny, M. J., R. A. Boyd, and B. M. Hall. 1997. Role of T cells in the mediation of Heymann nephritis. II. Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int. 51: 1059-1068.
23. Danilewicz, M., and M. Wagrowska-Danilewicz. 1995. Idiopathic membranous glomerulonephritis: a quantitative study of glomerular and interstitial lesions. Pol. J. Pathol. 46: 173-177.
24. + (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 18: 495-502.
25. Aversa, G., J. A. Waugh, and B. M. Hall. 1994. A monoclonal antibody (A6) recognizing a unique epitope restricted to CD45RO and RB isoforms of the leukocyte common antigen family identifies functional T cell subsets. Cell Immunol. 158: 314-328.
26. van Dixhoorn, M. G., J. J. Timmerman, D. J. Van Gijlswijk-Janssen, Y. Muizert, C. Verweij, R. G. Discipio, and M. R. Daha. 1997. Characterization of complement C6 deficiency in a PVG/c rat strain. Clin. Exp. Immunol. 109: 387-396.
27. Bhole, D., and G. L. Stahl. 2004. Molecular basis for complement component 6 (C6) deficiency in rats and mice. Immunobiology 209: 559-568.
28. Esser, A. F. 1994. The membrane attack complex of complement: assembly, structure and cytotoxic activity. Toxicology 87: 229-247.
29. Adler, S., P. J. Baker, P. Pritzl, and W. G. Couser. 1984. Detection of terminal complement components in experimental immune glomerular injury. Kidney Int. 26: 830-837.
30. Hara, M., S. R. Batsford, M. J. Mihatsch, D. Bitter-Suermann, and A. Vogt. 1991. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats: terminal complement components are not the sole mediators of proteinuria. Lab. Invest. 65: 168-179.
31. Savin, V. J., R. J. Johnson, and W. G. Couser. 1994. C5b-9 increases albumin permeability of isolated glomeruli in vitro. Kidney Int. 46: 382-387.
32. Pruchno, C. J., M. M. Burns, M. Schulze, R. J. Johnson, P. J. Baker, C. E. Alpers, and W. G. Couser. 1991. Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis. Am. J. Pathol. 138: 203-211.
33. Baker, P. J., R. F. Ochi, M. Schulze, R. J. Johnson, C. Campbell, and W. G. Couser. 1989. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am. J. Pathol. 135: 185-194.
34. Couser, W. G., R. F. Ochi, P. J. Baker, M. Schulze, C. Campbell, and R. J. Johnson. 1991. C6 depletion reduces proteinuria in experimental nephropathy induced by a non-glomerular antigen. J. Am. Soc. Nephrol. 2: 894-901.
35. Biesecker, G., and C. M. Gomez. 1989. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6. J. Immunol. 142: 2654-2659.
36. Sato, T., M. G. Van Dixhoorn, F. A. Prins, A. Mooney, N. Verhagen, Y. Muizert, J. Savill, L. A. Van Es, and M. R. Daha. 1999. The terminal sequence of complement plays an essential role in antibody-mediated renal cell apoptosis. J. Am. Soc. Nephrol. 10: 1242-1252.
37. Hughes, J., M. Nangaku, C. E. Alpers, S. J. Shankland, W. G. Couser, and R. J. Johnson. 2000. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. Am. J. Physiol. 278: F747-F757.
38. Nangaku, M., J. Pippin, and W. G. Couser. 1999. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J. Am. Soc. Nephrol. 10: 2323-2331.
39. Nangaku, M., C. E. Alpers, J. Pippin, S. J. Shankland, K. Kurokawa, S. Adler, R. J. Johnson, and W. G. Couser. 1997. Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9. Kidney Int. 52: 1570-1578.
40. Brauer, R. B., W. M. Baldwin, 3rd, M. R. Daha, S. K. Pruitt, and F. Sanfilippo. 1993. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J. Immunol. 151: 7240-7248.
41. Hansch, G. M., M. Betz, J. Gunther, K. O. Rother, and B. Sterzel. 1988. The complement membrane attack complex stimulates the prostanoid production of cultured glomerular epithelial cells. Int. Arch. Allergy Appl. Immunol. 85: 87-93.
42. Torbohm, I., M. Schonermark, A. M. Wingen, B. Berger, K. Rother, and G. M. Hansch. 1990. C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells. Kidney Int. 37: 1098-1104.
43. Hansch, G. M., M. Seitz, and M. Betz. 1987. Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. Int. Arch. Allergy Appl. Immunol. 82: 317-320.
44. Eddy, A. A., G. C. Ho, and P. S. Thorner. 1992. The contribution of antibody-mediated cytotoxicity and immune-complex formation to tubulointerstitial disease in passive Heymann nephritis. Clin. Immunol. Immunopathol. 62: 42-55.
45. Lianos, E. A., and B. Noble. 1989. Glomerular leukotriene synthesis in Heymann nephritis. Kidney Int. 36: 998-1002.
46. Neale, T. J., R. Ullrich, P. Ojha, H. Poczewski, A. J. Verhoeven, and D. Kerjaschki. 1993. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc. Natl. Acad. Sci. USA 90: 3645-3649.
47. - generation, MHC class II expression, and eicosanoid synthesis. Am. J. Pathol. 134: 431-437.
48. Sekse, I., B. M. Iversen, M. R. Daha, and J. Ofstad. 1992. Acute effect of passive Heymann nephritis on renal blood flow and glomerular filtration rate in the rat: role of the anaphylatoxin C5a and the α-adrenergic nervous system. Nephron 60: 453-459.
49. Oikawa, T., and A. Fogo. 1995. Mechanisms and significance of proteinuria. Nephrology 1: 95-103.
50. Arai, T., K. Morimoto, H. Masaoka, O. Kaneko, J. Mera, K. Kojima, M. Nagase, S. Kobayashi, T. Ohtake, and A. Hishida. 1997. Ultrastructural background of albuminuria in rats with passive Heymann nephritis. Nephrol. Dial. Transplant. 12: 2542-2548.
51. Hironaka, K., H. Makino, T. Onbe, Y. Yamasaki, K. Shikata, K. Kamata, and Z. Ota. 1996. Ultrastructural change of the glomerular basement membrane in rats with Heymann nephritis revealed by ultrahigh resolution scanning electron microscopy. J. Pathol. 179: 112-120.
52. Neale, T. J., P. P. Ojha, M. Exner, H. Poczewski, B. Ruger, J. L. Witztum, P. Davis, and D. Kerjaschki. 1994. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J. Clin. Invest. 94: 1577-1584.
53. Katoh, T., E. A. Lianos, M. Fukunaga, K. Takahashi, and K. F. Badr. 1993. Leukotriene D4 is a mediator of proteinuria and glomerular hemodynamic abnormalities in passive Heymann nephritis. J. Clin. Invest. 91: 1507-1515.
54. Mudge, S. J., K. Paizis, R. B. Auwardt, R. J. Thomas, and D. A. Power. 2001. Activation of nuclear factor-κB by podocytes in the autologous phase of passive Heymann nephritis. Kidney Int. 59: 923-931.
55. Levidiotis, V., C. Freeman, M. Punier, P. Marinello, B. Creese, V. Ferro, J. van der Vlag, J. H. Berden, C. R. Parish, and D. A. Power. 2004. A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis. J. Am. Soc. Nephrol. 15: 2882-2892.
56. Wu, H., G. Y. Zhang, and J. F. Knight. 2001. T cell receptor BV gene usage in interstitial cellular infiltrates in active Heymann nephritis. Nephrol. Dial. Transplant. 16: 1374-1381.
57. Wu, H., G. Walters, J. F. Knight, and S. I. Alexander. 2004. DNA vaccination against specific pathogenic TCRs reduces proteinuria in active Heymann nephritis by inducing specific autoantibodies. J. Immunol. 171: 4824-4829.
58. Rock, K. L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17: 131-137.
59. Coers, W., E. Brouwer, J. T. Vos, A. Chand, S. Huitema, P. Heeringa, C. G. Kallenberg, and J. J. Weening. 1994. Podocyte expression of MHC class I and II and intercellular adhesion molecule-1 (ICAM-1) in experimental pauci-immune crescentic glomerulonephritis. Clin. Exp. Immunol. 98: 279-286.
60. Hill, P. A., H. Y. Lan, D. J. Nikolic-Paterson, and R. C. Atkins. 1994. The ICAM-1/LFA-1 interaction in glomerular leukocytic accumulation in anti-GBM glomerulonephritis. Kidney Int. 45: 700-708.
61. Mendrick, D. L., D. M. Kelly, and H. G. Rennke. 1991. Antigen processing and presentation by glomerular visceral epithelium in vitro. Kidney Int. 39: 71-78.